Last reviewed · How we verify
NCT02872220
To Test for Photo Allergy Reaction of Sunscreens
NA trial testing SPF 50 Y65 110 (BAY987519) in Photoallergy in 56 participants. Completed in 8 May 2015.
8 May 2015
Quick facts
| Lead sponsor | Bayer |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | single |
| Primary purpose | other |
| Enrollment | 56 |
| Start date | 23 March 2015 |
| Primary completion | 8 May 2015 |
| Estimated completion | 8 May 2015 |
| Sites | 1 location across United States |
Drugs / interventions tested
- SPF 50 Y65 110 (BAY987519) — full drug profile →
- SPF 50 Y51 002 (BAY987519) — full drug profile →
- SPF 15 V27 104 (BAY987519) — full drug profile →
- Sodium chloride [NaCl] — full drug profile →
Conditions studied
- Photoallergy — all drugs for Photoallergy →
Sponsor
Bayer — full company profile →
Who can join
Adults 18 to 65, any sex, with Photoallergy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this tudy was to evaluate the potential of photoallergy of of sun care products Sun Protection Factor (SPF) 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 application compared to that of a negative control (0.9% sodium chloride, NaCl) and followed by irradiation with UV A and UVB. The secondary objective aims for evaluation of the safety of SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 combined with ultraviolet (UV) A/B irradiation by monitoring adverse events (AEs) throughout the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02872220
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SPF 50 Y65 110 (BAY987519)
Trials testing the same drug.
- NCT02802930 — Test the Phototoxicity of Sunscreen Products · NA · completed
Other Bayer trials
Trials by the same sponsor.
- NCT05900388 — A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolis · not yet recruiting
- NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
- NCT05477953 — An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About · not yet recruiting
- NCT07192952 — A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child · Phase 3 · not yet recruiting
- NCT07450599 — A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Befo · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02872220 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bayer
- Last refreshed: 12 December 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02872220.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing